New Year Address of Beroni Group

About
R&D
Core Businesses
Products
Investors
News
Contact
English

Menu

Home>
2018>
December>
29>
2018>
New Year Address of Beroni Group

New Year Address of Beroni Group

admin
2018-12-29
2018

You Might Also Like

The latest results of the ” Cancer New Drug PENAO” project are released!

2018-08-22

Beroni Group was invited to participate in the China-Japan-Korea Economic and Trade Cooperation Forum & Business Leaders Summit

2018-09-19

Beroni Group to Acquire Medicine-Plus

2018-06-20

Search Article

Arrange by Year

2017 (11)
2018 (25)
2019 (25)
2020 (9)
Uncategorized (1)

What’s New

Representatives of Huarong Securities Co., Ltd Visit Beroni Group
Strategic Cooperation between Beroni Group and BG Health
Beroni Group and Tianjin University have made a significant discovery in developing a medical solution using nanobody technology for the novel coronavirus
Beroni China (product: SARS-CoV-2 IgG/IgM Antibody Detection Kit) is included in the List of Medical Devices and Supplies Companies with Certification/Authorization from Other Countries
Beroni Group Announces Submission of Emergency Use Authorization to US FDA for its COVID-19 Rapid Test Detection Kit

Beroni Group is an international biotechnological company listed on the National Stock Exchange (Australia) and traded on the OTC markets in the USA with business presence in Australia, China, Japan and the USA. It currently has four core businesses – research and development of new drugs and clinical trail, immune cell therapy including gene detection and diagnosis, immunotherapy for cancer treatment, diagnosis of infectious diseases and e-commerce based on the Internet sales of pharmaceutical, healthcare and cosmetic products.

About

About Beroni
Our History
Board of Directors
Management Team
Vision, Mission, and Values

Core Businesses

Cell Therapy
Anti-Cancer Drugs
Infectious Diseases
E-Commerce

Products

By Beroni China
By Beroni Japan
By Beroni USA
By Medicine Plus

website by chase e-Design

Close Menu